Amrize (AMRZ) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 consolidated revenues rose 4.7% year-over-year to $2,178M, driven by strong demand and double-digit volume growth in Building Materials, while Building Envelope was impacted by soft roofing demand and a temporary plant disruption.
Adjusted EBITDA declined 10.3% to $192M, reflecting mixed segment performance and non-recurring costs.
Net loss widened to $118M from $87M in Q1 2025, with diluted loss per share at $(0.21).
PB Materials acquisition closed in February, contributing positively to results.
Board declared a $0.11 per share quarterly dividend and approved a $1.0B share repurchase program.
Financial highlights
Building Materials revenues up 12.9% to $1,500M; Adjusted EBITDA up 41.7% to $170M.
Building Envelope revenues down 9.8% to $678M; Adjusted EBITDA down 37.1% to $78M.
Q1 Capex totaled $272M, on track for $900M in 2026.
$1.1B in cash and equivalents; $4.3B total available liquidity as of March 31, 2026.
Free cash flow was a use of $1,163M, reflecting seasonal trends.
Outlook and guidance
2026 revenue guidance reaffirmed at $12.29B–$12.52B (+4% to +6% YoY).
Adjusted EBITDA guidance reaffirmed at $3.25B–$3.34B (+8% to +11% YoY).
Margin expansion targeted via ASPIRE program, aiming for 70bps in 2026 and $250M synergies by 2028.
Building Materials expected to benefit from price increases and strong volumes; Building Envelope expects improvement in H2 2026.
CapEx planned at $900M for 2026.
Latest events from Amrize
- 2026 guidance targets 4–6% revenue and 8–11% EBITDA growth, driven by strong demand and investments.AMRZ
Q4 202511 Apr 2026 - 2026 AGM proxy covers key votes, governance, compensation, and ESG priorities.AMRZ
Proxy Filing12 Mar 2026 - AGM to address board elections, executive pay, distributions, and non-financial reporting.AMRZ
Proxy Filing12 Mar 2026 - 2026 AGM proxy covers financials, compensation, board elections, and strong governance initiatives.AMRZ
Proxy Filing27 Feb 2026 - Stable Q2 2025 results and synergy program support strong outlook and long-term growth.AMRZ
Q2 202523 Nov 2025 - Q3 revenue up 6.6% to $3,675M, net income $543M, 2025 guidance raised to $12.0B.AMRZ
Q3 202529 Oct 2025